According to scPharmaceuticals's latest financial reports the company has $58.44 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $76.01 M | -35.68% |
2022-12-31 | $0.11 B | 57% |
2021-12-31 | $75.27 M | -28.37% |
2020-12-31 | $0.10 B | 44.71% |
2019-12-31 | $72.62 M | -18.84% |
2018-12-31 | $89.47 M | -24.36% |
2017-12-31 | $0.11 B | 201.15% |
2016-12-31 | $39.28 M | 2397.27% |
2015-12-31 | $1.57 M |